Ligand Pharmaceuticals (LGND) Enterprise Value (2010 - 2026)
Ligand Pharmaceuticals (LGND) reported Enterprise Value of $4.94 billion for Q2 2026, up 151.8% from $1.96 billion a year earlier and up 53.4% from the prior quarter.
Ligand Pharmaceuticals (LGND) Enterprise Value (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ligand Pharmaceuticals' Enterprise Value came in at $2.76 billion, up 116.2% year-over-year; for FY2025, it was $3.01 billion, up 67.8% from FY2024.
- Enterprise Value has increased for three consecutive years, with a five-year compound annual growth rate of 38.7% (FY2020 to FY2025).
- By year, Enterprise Value came in at $1.79 billion in FY2024 (+65.3%), $1.08 billion in FY2023 (+17.7%), $920.46 million in FY2022 (-27.8%) and $1.27 billion in FY2021 (+117.3%).
- The Q2 2026 figure ranks as the highest quarterly Enterprise Value in data going back to Q2 2010.
- Year over year, Enterprise Value has now increased in each of the last 13 quarters, with growth averaging 82.4% over the last eight quarters.
- The high point for year-over-year Enterprise Value in five years was Q3 2021 (growth of 598.1%); the low point was Q3 2022 (a decline of 30.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.22 billion (Q1 2026), $3.01 billion (Q4 2025) and $2.82 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.94 Bn |
| Mar 31, 2026 | 3.22 Bn |
| Dec 31, 2025 | 3.01 Bn |
| Sep 30, 2025 | 2.82 Bn |
| Jun 30, 2025 | 1.96 Bn |
| Mar 31, 2025 | 1.82 Bn |
| Dec 31, 2024 | 1.79 Bn |
| Sep 30, 2024 | 1.66 Bn |
| Jun 30, 2024 | 1.30 Bn |
| Mar 31, 2024 | 999.65 Mn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 30, 2023 | 853.36 Mn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 977.71 Mn |
| Dec 31, 2022 | 920.46 Mn |
| Sep 30, 2022 | 786.14 Mn |
| Jun 30, 2022 | 791.72 Mn |
| Mar 31, 2022 | 979.14 Mn |
| Dec 31, 2021 | 1.27 Bn |
| Sep 30, 2021 | 1.13 Bn |
Ligand Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=LGND&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();